Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE

NCT07253701 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT07253701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07253701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Recruiting
Start date
February 27, 2024
Completion date
March 31, 2028
Enrollment
1,500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker discovery, epilepsy, metabolomics, microbiota, proteomics